Age, years, mean ± SD |
55.40 ± 11.54 |
49.60 ± 13.92 |
0.01 |
Gender |
|
|
0.34 |
Male |
62 (75.6) |
75 (81.5) |
|
Female |
20 (24.4) |
17 (18.5) |
|
Race |
|
|
0.63 |
African American |
54 (65.9) |
59 (64.1) |
|
Caucasian |
27 (32.9) |
33 (35.9) |
|
Other |
1 (1.2) |
0 |
|
Body mass index, kg/m2, mean ± SD |
28.20 ± 6.15 |
28.50 ± 5.74 |
0.50 |
Comorbidities |
|
|
|
Diabetes |
28 (34.1) |
31 (33.7) |
0.86 |
Dyslipidemia |
41 (50.0) |
47 (51.1) |
0.89 |
Hypertension |
71 (86.6) |
73 (79.4) |
0.21 |
Chronic obstructive pulmonary disease |
11 (13.4) |
11 (12.0) |
0.77 |
Cerebrovascular disease |
13 (15.9) |
15 (16.3) |
0.96 |
Cardiac surgery before the implant |
|
|
0.23 |
None |
71 (86.6) |
85 (92.4) |
|
CABG |
7 (8.5) |
5 (5.4) |
|
Valvular repair |
0 (0) |
1 (1.1) |
|
Other |
4 (4.9) |
1 (1.1) |
|
Preoperative laboratory values, mean ± SD |
|
|
|
Total bilirubin, mg/dL |
1.10 ± 0.61 |
1.20 ± 1.05 |
0.65 |
Sodium, mEq/L |
135 ± 3.10 |
135 ± 3.60 |
0.38 |
Creatinine, mg/dL |
1.30 ± 0.34 |
1.40 ± 0.55 |
0.22 |
International normalized ratio |
1.08 ± 0.16 |
1.13 ± 0.18 |
0.04 |
Lactate dehydrogenase, U/L |
284 ± 95.10 |
397 ± 310.70 |
0.06 |
MELD score, mean ± SD |
11.40 ± 4.55 |
12.80 ± 5.11 |
0.09 |
Indication for implant |
|
|
0.05 |
Bridge to transplant |
11 (13.4) |
23 (25.0) |
|
Destination therapy |
71 (86.6) |
69 (75.0) |
|
Preoperative echocardiogram findings, mean ± SD |
|
|
|
Ejection fraction, % |
15.80 ± 6.47 |
15.50 ± 6.09 |
0.91 |
Left ventricular end-diastolic diameter, cm |
7.30 ± 1.00 |
7.30 ± 0.87 |
0.70 |
Left ventricular end-systolic diameter, cm |
6.70 ± 1.04 |
6.70 ± 0.94 |
0.91 |
TAPSE, cm |
1.70 ± 0.41 |
1.70 ± 0.47 |
0.38 |
S-prime, cm/s |
10.60 ± 2.83 |
9.80 ± 2.29 |
0.11 |
Preoperative right heart catheterization, mean ± SD |
|
|
|
CVP, mm Hg |
9.10 ± 5.45 |
9.50 ± 5.80 |
0.80 |
PAS, mm Hg |
52.70 ± 17.14 |
52.30 ± 14.64 |
0.99 |
PAD, mm Hg |
23.80 ± 9.31 |
23.10 ± 8.19 |
0.64 |
PAPi |
4.90 ± 4.32 |
4.70 ± 3.94 |
0.91 |
Tandem/Impella/ECMO as assist device |
0 (0) |
7 (7.6) |
0.01 |
INTERMACS profile |
|
|
0.17 |
1 |
6 (7.3) |
17 (18.5) |
0.04 |
2 |
54 (65.9) |
51 (55.4) |
0.17 |
3 |
21 (25.6) |
23 (25.0) |
0.99 |
4 |
1 (1.2) |
1 (1.1) |
0.99 |
New York Heart Association classification |
|
|
0.69 |
III |
2 (2.4) |
4 (4.4) |
** |
IV |
80 (97.6) |
88 (95.6) |
** |